Russell K. Portenoy

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

Roger Chou, Gilbert J. Fanciullo, Perry G. Fine et al. · Journal of Pain · 2009 · 2.2K citations · Full text

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

Russell K. Portenoy, Howard T. Thaler, Alice B. Kornblith et al. · European Journal of Cancer · 1994 · 1.6K citations

Psychological Co-morbidities, Symptom Prevalence, Psychiatry +6

Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

Gregory A. Curt, William Breitbart, David Cella et al. · The Oncologist · 2000 · 1.2K citations

Defining the clinically important difference in pain outcome measures

John T. Farrar, Russell K. Portenoy, Jesse A. Berlin et al. · Pain · 2000 · 1.1K citations